Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury

Journal of Pineal Research

Volumn 54, Issue 2, 2013, Pages 207-221

  Yip, Hon Kan ^a   Chang, Yi Chih ^b   Wallace, Christopher Glenn ^c   Chang, Li Teh ^d   Tsai, Tzu Hsien ^a   Chen, Yung Lung ^a   Chang, Hsueh Wen ^e   Leu, Steve ^a   Zhen, Yen Yi ^a   Tsai, Ching Yen ^f   Yeh, Kuo Ho ^a   Sun, Cheuk Kwan ^g   Yen, Chia Hung ^h  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d MEIHO UNIVERSITY   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^f INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^g I SHOU UNIVERSITY   (Taiwan)

^h NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

acute ischemia reperfusion lung injury; adipose derived mesenchymal stem cells; inflammation; melatonin; oxidative stress

Indexed keywords

ANGIOTENSIN RECEPTOR; CASPASE 3; CD31 ANTIGEN; CD68 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MELATONIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN BAX; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ADIPOSE DERIVED MESENCHYMAL STEM CELL THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERIAL OXYGEN SATURATION; ARTICLE; CONTROLLED STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BLOTTING, WESTERN; IMMUNOHISTOCHEMISTRY; MALE; MELATONIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STEM CELL TRANSPLANTATION;

EID: 84873482831     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12020     Document Type: Article

References (40)

1. Brun-buisson C, Minelli C, Bertolini G, et al. Epidemiology and outcome of acute lung injury in European intensive care units results from the ALIVE study. Intensive Care Med 2004; 30: 51-61.
2. Matthay MA, Zimmerman GA,. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005; 33: 319-327.
3. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-1693.
4. Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009; 179: 220-227.
5. Ailawadi G, Lau CL, Smith PW, et al. Does reperfusion injury still cause significant mortality after lung transplantation? J Thorac Cardiovasc Surg 2009; 137: 688-694.
6. Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002; 73: 1041-1047.
7. Ware LB, Matthay MA,. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
8. Ciesla DJ, Moore EE, Johnson JL, et al. The role of the lung in post injury multiple organ failure. Surgery 2005; 138: 749-757.
9. den Hengst WA, Gielis JF, Lin JY, et al. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 2010; 299: H1283-H1299.
10. Brower RG, Lanken PN, Maclntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327-336.
11. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-2575.
12. Dunne PJ, Macintyre NR, Schmidt UH, et al. Respiratory care year in review 2011: long-term oxygen therapy, pulmonary rehabilitation, airway management, acute lung injury, education, and management. Respir Care 2012; 57: 590-606.
13. Jiang H, Huang Y, Xu H, et al. Inhibition of hypoxia inducible factor-1α ameliorates lung injury induced by trauma and hemorrhagic shock in rats. Acta Pharmacol Sin 2012; 33: 635-643.
14. Oyaizu T, Fung SY, Shiozaki A, et al. Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury. Intensive Care Med 2012; 38: 894-905.
15. Dolinay T, Kim YS, Howrylak J, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 2012; 185: 1225-1234.
16. Bhargava M, Wendt CH,. Biomarkers in acute lung injury. Transl Res 2012; 159: 205-217.
17. Ali I, Gruenloh S, Gao Y, et al. Protection by 20-5,14-HEDGE against surgically induced ischemia reperfusion lung injury in rats. Ann Thorac Surg 2012; 93: 282-288.
18. Bittner HB, Binner C, Dahlberg P, et al. Reducing ischemia-reperfusion injury in clinical lung transplantation. Transplant Proc 2007; 39: 489-492.
19. Botha P, Jeyakanthan M, Rao JN, et al. Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 2007; 26: 1199-1205.
20. Sun CK, Yen CH, Lin YC, et al. Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J Transl Med 2011; 9: 118-130.
21. Stehle JH, Saade A, Rawashdeh O, et al. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
22. Reiter RJ, Paredes SD, Manchester LC, et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44: 175-200.
23. Poeggeler B, Saarela S, Reiter RJ, et al. Melatonin-a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci 1994; 738: 419-420.
24. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
25. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
26. Diez ER, Prados LV, Carriõn A, et al. A novel electrophysiologic effect of melatonin on ischemia/reperfusion-induced arrhythmias in isolated rat hearts. J Pineal Res 2009; 46: 155-160.
27. Kang JW, Koh EJ, Lee SM,. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J Pineal Res 2011; 50: 403-411.
28. Kilic U, Yilmaz B, Ugur M, et al. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 2012; 52: 228-235.
29. Inci I, Inci D, Dutly A, et al. Melatonin attenuates posttransplant lung ischemia-reperfusion injury. Ann Thorac Surg 2002; 73: 220-225.
30. Okutan H, Savas C, Delibas N, et al. The antioxidant effect of melatonin in lung injury after aortic occlusion-reperfusion. Interact Cardiovasc Thorac Surg 2004; 3: 519-522.
31. Blanc KL, Tammik L, Sundberg B,. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20.
32. Thum T, Bauersachs J, Poole-Wilson PA,. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005; 46: 1799-1802.
33. Patschan D, Hildebrandt A, Rinneburger J, et al. The hormone melatonin stimulates renoprotective effects of "early outgrowth" endothelial progenitor cells in acute ischemic kidney injury. Am J Physiol Renal Physiol 2012; 302: F1305-F1312.
34. Mias C, Troouche E, Seguelas MH, et al. Ex vivo pretreatment with melatonin improvessurvival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 2008; 26: 1749-1757.
35. Cheung RT, Tipoe GL, Tam S, et al. Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. J Pineal Res 2006; 41: 337-343.
36. Zhu W, Chen J, Cong X, et al. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006; 24: 416-425.
37. Sun CK, Lee FY, Sheu JJ, et al. Early combined therapy with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats. J Pharmacol Exp Ther 2009; 330: 718-726.
38. Chen YT, Sun CK, Lin YC, et al. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 2011; 52: 153-158.
39. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New Eng J Med 2006; 355: 1210-1221.
40. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New Eng J Med 2006; 355: 1199-1209.